Holen Sie sich die Stockscreener-App
1.01
0.50%
0.005
Handel nachbörslich:
.99
-0.02
-1.98%
Health In Tech Inc Aktie (HIT) Neueste Nachrichten
Craig-Hallum Reaffirms Their Buy Rating on Health In Tech, Inc. Class A (HIT) - The Globe and Mail
HIT Maintains Buy Rating -- Price Target Lowered to $3.00 by Max - GuruFocus
Health In Tech, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
HIT|Health In Tech Inc|Price:1.005|Chg%:-0.055 - TradingKey
Health In Tech Q2 Revenue Falls 13.5% on Carrier Onboarding Timing Shift - Minichart
Health In Tech Inc (HIT) (Q2 2026) Earnings Call Highlights: Strategic Carrier Shift and Hitrix ... By GuruFocus - Investing.com Canada
Health In Tech (HIT) Q2 Revenue Declines Amid Strategic Shift; M - GuruFocus
Health In Tech, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HIT) 2026-08-13 - Seeking Alpha
Health In Tech Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Health In Tech misses Q2 2026 profit view as shares fall - Investing.com
Health In Tech Q2 2026 Earnings Call: Complete Transcript - Benzinga
Health In Tech Highlights Q2 Results and AI Platform Growth - TipRanks
Health In Tech Inc reports results for the quarter ended June 30Earnings Summary - tradingview.com
Health In Tech Q2 2026 Earnings Call Transcript - MarketBeat
Health In Tech holds earnings call for second quarter results - Investing.com
Form 8K Health In Tech Inc For: 13 August By Investing.com - Investing.com Canada
Health In Tech Highlights AI-Driven Self-Funded Benefits Platform - TipRanks
Health In Tech (HIT) Q2 2026 revenue dips as it reaffirms $45–$50M outlook - Stock Titan
Health In Tech Latest Results: FY26 sales guidance affirmed at $45M-$50M - scanx.trade
Health In Tech Q2 Results: EPS Misses Estimate, Sales Beat - scanx.trade
HIT: 2026 revenue guidance reaffirmed at $45M–$50M despite recent margin and revenue declines - TradingView
Health In Tech (HIT) reaffirms 2026 $45–$50M revenue outlook amid margin pressure - Stock Titan
Health In Tech (HIT) swings to Q2 2026 loss but reaffirms $45–$50M guidance - Stock Titan
Health In Tech (HIT) posts H1 2026 loss, cuts revenue with carrier adjustment - Stock Titan
Health In Tech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Health in Tech, Inc. Reaffirms Earnings Guidance for the Full-Year 2026 - marketscreener.com
Health In Tech (HIT) 10K Form and Latest SEC Filings 2026 - MarketBeat
Health In Tech Inc (HIT) Q2 2026 Earnings Report Preview: What To Expect - Yahoo Finance
Health In Tech Inc expected to post a loss of 2 cents a shareEarnings Preview - tradingview.com
Health In Tech Inc. Class A (HIT) Live Share Price, Invest From India - INDmoney
Health In Tech Inc (HIT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Yidu Tech Inc. (2158.HK) stock price, news, quote and history - Yahoo Finance Australia
/C O R R E C T I O N — Health In Tech, Inc./ - Morningstar
Health In Tech to Announce Second Quarter 2026 Financial Results on August 13, 2026 - The Malaysian Reserve
/C O R R E C T I O N -- Health In Tech, Inc./ - AOL.com
Health In Tech corrects earnings release date to Thursday, Aug. 13 - Bitget
Health In Tech Inc. (HIT) Experiences Modest Decline – Key Levels in FocusDividend ETF - dars.gov.et
HIT|Health In Tech Inc|Price:1.070|Chg%:+0.010 - TradingKey
Health In Tech Inc (HIT) Income Statement - TradingKey
Health In Tech, Inc. SEC Filing (Jul 23, 2026) - Stock Titan
Knox Lane acquires health tech firm Cross Country Healthcare Inc - pehub.com
Form 4 Health In Tech Inc For: 17 July By Investing.com - Investing.com South Africa
Health In Tech (HIT) exec surrenders 4,084 shares to cover taxes - Stock Titan
Health In Tech (HIT) CEO withholds 47,217 shares to cover tax bill - Stock Titan
Health In Tech (HIT) CFO surrenders 28,725 shares for tax - Stock Titan
Health In Tech, Inc. (NASDAQ:HIT) Sees Large Drop in Short Interest - MarketBeat
Health In Tech (NASDAQ:HIT) Shares Down 2.8%Here's What Happened - MarketBeat
Form 4 Health In Tech Inc For: 10 July By Investing.com - Investing.com India
Health In Tech (HIT) director granted 18,867 vested restricted shares - Stock Titan
Health In Tech, Inc. (NASDAQ: HIT) awards 18,867 restricted shares to director - Stock Titan
Health In Tech (HIT) director receives 18,867-share restricted stock award - Stock Titan
Price to earnings forward of Health In Tech, Inc. – NASDAQ:HIT - TradingView
Health In Tech (HIT) Joins Russell Microcap Index - GuruFocus
Health In Tech, Inc.(NasdaqCM: HIT) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Health In Tech Added to Membership of Russell Microcap® Index - Barchart.com
Health In Tech, Inc.(NasdaqCM: HIT) added to Russell 3000E Growth Benchmark - marketscreener.com
Health In Tech, Inc.(NasdaqCM: HIT) added to Russell Microcap Index - marketscreener.com
2.91%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):